| View |
|
DRP-15507
|
Oxaliplatin
|
Oxalis 50
|
5 mg/mL (50 mg/10mL)
|
Solution for Injection (IV
Infusion)
|
Antineoplastic
|
Alwin DMD Pharmaceuticals
|
India
|
Initial
|
30 July 2024
|
30 July 2029
|
| View |
|
DRP-15506
|
Oxaliplatin
|
Oxalis 100
|
5 mg/mL (100 mg/20mL)
|
Solution for Injection (IV
Infusion)
|
Antineoplastic
|
Alwin DMD Pharmaceuticals
|
India
|
Initial
|
30 July 2024
|
30 July 2029
|
| View |
|
DRP-15515
|
Tramadol hydrochloride + Paracetamol
|
Paratram
|
37.5 mg/325 mg
|
Film-Coated Tablet
|
Opioid Analgesic
|
Getz Pharma Pvt. Ltd.
|
Pakistan
|
Initial
|
30 July 2024
|
30 July 2029
|
| View |
|
DRP-15490
|
Ampicillin (as sodium) + Sulbactam (as sodium)
|
Baczillin
|
1 g/500 mg
|
Powder for Injection (IM/IV)
|
Antibacterial (Beta-lactam Antibacterial, Penicillin)
|
North China Pharmaceutical Co., Ltd.
|
China
|
Initial
|
30 July 2024
|
30 July 2029
|
| View |
|
DRP-15487
|
Amlodipine (as besilate) + Atorvastatin
|
None
|
5 mg/20 mg
|
Film-Coated Tablet
|
Calcium Channel Blocker/ HMG CoA Reductase
Inhibitor
|
Novagen Healthcare Private Limited
|
India
|
Initial
|
30 July 2024
|
30 July 2026
|
| View |
|
DRP-15491
|
Ampicillin (as sodium) + Sulbactam (as sodium)
|
Baczillin
|
500 mg/250 mg
|
Powder for Injection (IM/IV)
|
Antibacterial (Beta-lactam Antibacterial, Penicillin)
|
North China Pharmaceutical Co., Ltd.
|
China
|
Initial
|
30 July 2024
|
30 July 2029
|
| View |
|
DRP-15486
|
Amlodipine (as besilate) + Atorvastatin
|
None
|
5 mg/10 mg
|
Film-Coated Tablet
|
Calcium Channel Blocker /HMG CoA Reductase
Inhibitor
|
Novagen Healthcare Private Limited
|
India
|
Initial
|
30 July 2024
|
30 July 2026
|
| View |
|
DRP-15518
|
Amorolfine (as hydrochloride)
|
Canrolfin
|
2.5 mg/g (0.25% w/w)
|
Cream
|
Antifungal
|
KLM Laboratories Pvt. Ltd
|
India
|
Initial
|
30 July 2024
|
30 July 2029
|
| View |
|
DRP-15513
|
Betamethasone (as valerate)
|
Betno-B
|
1 mg/g (0.1% w/w)
|
Topical Cream
|
Corticosteroid
|
Rhydbrug Pharmaceuticals Limited
|
India
|
Initial
|
30 July 2024
|
30 July 2029
|
| View |
|
DRP-15514
|
Betamethasone (as valerate)
|
Veeta
|
1 mg/g (0.1% w/w)
|
Topical Cream
|
Corticosteroid
|
Rhydbrug Pharmaceuticals Limited.
|
India
|
Initial
|
30 July 2024
|
30 July 2029
|
| View |
|
DRP-15501
|
Atorvastatin (as calcium trihydrate)
|
Xantor
|
10 mg
|
Film-Coated Tablet
|
HMG COA Reductase Inhibitor
|
Lek S.A.
|
Poland
|
Initial
|
29 July 2024
|
29 July 2029
|
| View |
|
DRP-15500
|
: Atorvastatin (as calcium trihydrate)
|
Xantor
|
20 mg
|
Film-Coated Tablet
|
HMG COA Reductase Inhibitor
|
Lek S.A.
|
Poland
|
Initial
|
29 July 2024
|
29 July 2029
|
| View |
|
DRP-15499
|
Atorvastatin (as calcium trihydrate)
|
Xantor
|
40 mg
|
Film-Coated Tablet
|
HMG COA Reductase Inhibitor
|
Lek S.A.
|
Poland
|
Initial
|
29 July 2024
|
29 July 2029
|
| View |
|
DRP-15498
|
Atorvastatin (as calcium trihydrate)
|
Xantor
|
80 mg
|
Film-Coated Tablet
|
HMG COA Reductase Inhibitor
|
Lek S.A.
|
Poland
|
Initial
|
29 July 2024
|
29 July 2029
|
| View |
|
DRP-15510
|
Valsartan
|
Viosan
|
160 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
The Government Pharmaceutical Organization.
|
Thailand
|
Initial
|
30 July 2024
|
30 July 2029
|
| View |
|
DRP-15508
|
Cefazolin (as sodium)
|
Cefazoget
|
1 g
|
Powder for Solution for Injection (IM/IV/IV Infusion)
|
First-Generation Cephalosporin
|
Swiss Parenterals Ltd.
|
India
|
Initial
|
30 July 2024
|
30 July 2029
|
| View |
|
DRP-15509
|
Cefoxitin (as sodium)
|
CefoxiGet
|
1 g
|
Powder for Solution for Injection (IM/IV)
|
Second-Generation Cephalosporin
|
Swiss Parenterals Ltd.
|
India
|
Initial
|
30 July 2024
|
30 July 2029
|
| View |
|
DRP-15512
|
Carboplatin
|
None
|
10 mg/mL (150 mg/ 15 mL and 450 mg/ 45 mL)
|
Concentrate Solution for IV Infusion
|
Platinum Compound
|
Therdose Pharma Pvt. Ltd.
|
India
|
Initial
|
30 July 2024
|
30 July 2029
|
| View |
|
DRP-15511
|
Carboplatin
|
Neothix
|
10 mg/mL (150 mg/ 15 mL and 450 mg/ 45 mL)
|
Concentrate Solution for IV Infusion
|
Platinum Compound
|
Therdose Pharma Pvt. Ltd.
|
India
|
Initial
|
30 July 2024
|
30 July 2029
|
| View |
|
DRP-15517
|
Febuxostat
|
Febuzen 40
|
40 mg
|
Film-Coated Tablet
|
Antigout Preparation
|
Akriti Pharmaceuticals Pvt. Ltd.
|
India
|
Initial
|
30 July 2024
|
30 July 2029
|